Our findings suggest that promoter methylation of CLIP4, IRF4, ELMO1, and MSC, together with a GDMI > 4, is a useful molecular panel for gastric cancer risk stratification in endoscopic biopsies (Figure 5). Here, CLIP4 is linked to gastric cancer.